VANCOUVER, Sept. five, 2019 /PRNewswire/ – Pivot Pharmaceuticals Inc. (CSE: PVOT/OTCQB: PVOTF/ FRA: NPAT) is pleased to announce that it has entered into a binding letter of intent to acquire 51%of iAmHealth, an on the web nutraceutical distribution and sales platform serving the EU marketplace.
The strategic acquisition of iAmHealth (https://www.iam.overall health) will supply Pivot with an quick on the web retailer and virtual footprint for its solution portfolio of water soluble, shelf steady and sophisticated bioavailable CBD formulations. Pivot and iAmHealth will with each other concentrate on CBD associated merchandise and on merchandise making use of micelle technologies for vitamin supplements, energy drinks, other nutraceutical merchandise, and merchandise supporting cancer sufferers throughout radiation and chemo therapy, tapping into the quickly-expanding nutraceutical marketplace in important European markets. iAmHealth merchandise have been tested and applied in connected medical doctor and physiotherapist practices prior to industrial launch.
Essential Highlights :
- Initial Pivot presence in 3 important European markets – Germany, Czech Republic and Slovakia.
- Pivot’s CBD merchandise to be introduced as important addition to the retailer’s nutraceutical merchandise category, to help sales and brand awareness.
- Accelerates Pivot’s multi-channel brand distribution technique targeting the European CBD, nutraceutical and wellness markets.
Dr. Toni Rinow, CEO of Pivot Pharmaceuticals comments: “Pivot will be place on a path of accelerated income development and international expansion in important cannabis markets in Canada, United States, and the European Union to come to be a cannabis leader in the pharmaceutical, OTC, nutraceutical and wellness markets.”
The transaction closing is subject to the execution of a definitive agreement by not later than December 31, 2019.
About iAmHealth :
Please come across far more information and facts at https://www.iam.overall health
About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc. is a science-primarily based, customer packaged goods cannabis corporation engaged in the improvement and commercialization of overall health and wellness merchandise making use of revolutionary, patent-protected drug delivery technologies. Upon receipt of Common Processor and Health-related Sales licenses (pending) from Overall health Canada, Pivot’s premium, bioavailable, steady and helpful merchandise will be manufactured at its 50,000-sq. ft. cGMP facility situated in Montreal, Quebec. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals, LLC, primarily based in Costa Mesa, California, was granted a Provisional Annual Manufacturing License Variety N: Infusion License by the California Division of Public Overall health in May perhaps 2019 and a Provisional Adult-Use and Medicinal – Distributor-Transport License by the Bureau of Cannabis Manage in June 2019. Pivot’s solution line will contain infused beverages, vegan capsules, dissolvable tablets, topical creams and gels, intimate lubricants, roll-on discomfort relievers, stick packs, and bulk powder for the edibles marketplace.
For far more information and facts please take a look at pivotpharma.com
Cautionary Note With regards to Forward-Seeking Statements
Except for historical information and facts contained herein, the matters set forth above could be forward-hunting statements that involve particular dangers and uncertainties that could result in actual outcomes to differ from these in the forward-hunting statements. Words such as anticipate, believe, estimate, count on, intend, and related expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Overall health Options Inc., Pivot Naturals, LLC, or its management or the completion of the private placement, recognize forward-hunting statements. Such forward-hunting statements are primarily based on the existing beliefs of management, as nicely as assumptions created by and information and facts at present out there to management. Actual outcomes could differ materially from these contemplated by the forward-hunting statements as a outcome of particular aspects, such as the failure to meet the circumstances imposed by the CSE or other securities regulators, the level of company and customer spending, the quantity of sales of Pivot’s merchandise, statements with respect to internal expectations, the competitive atmosphere inside the business, the potential of Pivot to continue to expand its operations, the level of expenses incurred in connection with Pivot’s expansion efforts, financial circumstances in the business, and the monetary strength of Pivot’s prospects and suppliers. Pivot does not undertake any obligation to update such forward-hunting statements. Investors are also directed to look at all other dangers and uncertainties.
Get True-Time Updates from The Every day Marijuana Observer